All Stories

  1. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care: FIGURE 1.
  2. Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy
  3. Guideline
  4. Transplantation: clinical studies - A
  5. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations
  6. Is it time to give up with calcineurin inhibitors in kidney transplantation?
  7. High Platelet Turnover and Reactivity in Renal Transplant Recipients Patients
  8. Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing
  9. Contrast-Enhanced Ultrasound Assessment of Complex Cystic Lesions in Renal Transplant Recipients With Acquired Cystic Kidney Disease: Preliminary Experience
  10. Conversion From Calcineurin Inhibitors to Everolimus With Low-Dose Cyclosporine in Renal Transplant Recipients With Squamous Cell Carcinoma of the Skin
  11. Relationship Among Endothelial Response to Hyperemia, Bone Marrow-Derived Progenitor Cells, and Parathyroid Hormone in Renal Transplantation
  12. Antineoplastic effects of mammalian target of rapamycine inhibitors
  13. Renal transplant allocation criteria, desensitization strategies and immunosuppressive therapy in retransplant renal patients
  14. The Kidney, a Victim and Culprit of Autoimmune and Alloimmune Responses
  15. The Florence Register of amyloidosis: 20 years' experience in the diagnosis and treatment of the disease in the Florence district area
  16. Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study
  17. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement
  18. Long-term outcome of everolimus treatment in transplant patients
  19. Renin angiotensin system blockade and activated vitamin D as a means of preventing deep vein thrombosis in renal transplant recipients
  20. Genome-wide association study identifies susceptibility loci for IgA nephropathy
  21. What is the purpose of launching the World Journal of Transplantation?
  22. Good outcomes with Cyclosporine very low exposure with Everolimus high exposure in renal transplant patients
  23. High platelet turnover and reactivity in renal transplant recipients patients
  24. Everolimus With Very Low-Exposure Cyclosporine A in De Novo Kidney Transplantation: A Multicenter, Randomized, Controlled Trial
  25. High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients
  26. Sexual Dysfunction in Women During Dialysis and after Renal Transplantation
  27. Pretransplant Positivity for Circulating Thyroid Antibodies and Graft Survival in Patients Undergoing Kidney Transplant
  28. Post‐transplant proteinuria associated with everolimus: Definition of main features with proteomics
  29. Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms
  30. European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP)
  31. Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure
  32. Efficacy and safety of enteric‐coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials
  33. Randomized Controlled Trial of FTY720 Versus MMF in De Novo Renal Transplantation
  34. Mycophenolic Acid Use in Glomerulonephritis
  35. Follow-up after renal transplantation with organs from donors after cardiac death
  36. A young woman with oedema
  37. Enteric-coated mycophenolate sodium: role in transplantation
  38. A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopathic Membranous Nephropathy
  39. Estimated One-Year Glomerular Filtration Rate is the Best Predictor of Long-term Graft Function Following Renal Transplant
  40. High Rate of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism
  41. Nephrotic Syndrome and Renal Failure After Allogeneic Stem Cell Transplantation: Novel Molecular Diagnostic Tools for a Challenging Differential Diagnosis
  42. Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF), it is Better to Have the Choice
  43. High CXCL10 Expression in Rejected Kidneys and Predictive Role of Pretransplant Serum CXCL10 for Acute Rejection And Chronic Allograft Nephropathy
  44. Mycophenolate Sodium Delayed Release
  45. Performance of Different Prediction Equations for Estimating Renal Function in Kidney Transplantation
  46. High Pretransplant Serum Levels of CXCL10/IP-10 Are Related to Increased Risk of Renal Allograft Failure
  47. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
  48. In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: Insights from the MY.S.S. Trial
  49. Enteric Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novoRenal Transplant Patients
  50. Changes in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena?
  51. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients
  52. A RANDOMIZED, DOUBLE-BLIND TRIAL OF BASILIXIMAB IMMUNOPROPHYLAXIS PLUS TRIPLE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS1,2
  53. HIGH CYSTEINE LEVELS IN RENAL TRANSPLANT RECIPIENTS
  54. HYPERHOMOCYSTEINEMIA IN RENAL TRANSPLANT PATIENTS AS INDEPENDENT CAUSE OF ENDOTHELIAL DAMAGE AND CARDIOVASCULAR DISEASE.
  55. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
  56. Graft versus host antibody reactions in abo unmatched renal transplants
  57. Persistent parvovirus B19 infections with different clinical outcomes in renal transplant recipients: diagnostic relevance of polymerase chain reaction (PCR) and of quantification of B19 DNA in sera
  58. Functional study of autonomic neuropathy in primary (AL) amyloidosis
  59. Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma
  60. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV
  61. Long Term Efficacy of High-Dose Intravenous Methylprednisolone Pulses in Active Lupus Nephritis: A 21-month prospective study
  62. Aging on the waiting list: should it be a further criterion for cadaver kidney allocation?
  63. Dialysis & Transplantation
  64. Dialysis & Transplantation